A detailed history of Gamma Investing LLC transactions in Mannkind Corp stock. As of the latest transaction made, Gamma Investing LLC holds 458 shares of MNKD stock, worth $3,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares
458
Previous 80 472.5%
Holding current value
$3,114
Previous $418,000 589.23%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$5.01 - $6.7 $1,893 - $2,532
378 Added 472.5%
458 $2.88 Million
Q2 2024

Jul 02, 2024

BUY
$4.05 - $5.43 $324 - $434
80 New
80 $418,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.75B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.